Name
OÜ Perearst Maire Nõmm
Registry code
14854243
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
22.11.2019 (4)
Financial year
01.01-31.12
Capital
2 676.00 €
Activity
86211 - Provision of general medical treatment
385 879 €
54 452 €
14%
-
67 160 €
0
Submitted
No tax arrears
81%
48%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Maire Nõmm 10.11.1965 (58) | 100% - 2 676.00 EUR | Board member | Direct ownership | Founder |
| 2020 29.06.2021 | 2021 29.06.2022 | 2022 28.06.2023 | 2023 27.06.2024 | |
|---|---|---|---|---|
| Total Revenue | 261 960 € | 301 374 € | 338 264 € | 385 879 € |
| Net profit (loss) for the period | 66 830 € | 58 619 € | 44 583 € | 54 452 € |
| Profit Margin | 26% | 19% | 13% | 14% |
| Current Assets | 77 827 € | 98 595 € | 108 769 € | 103 968 € |
| Fixed Assets | 31 252 € | 23 571 € | 16 539 € | 8 711 € |
| Total Assets | 109 079 € | 122 166 € | 125 308 € | 112 679 € |
| Current Liabilities | 23 822 € | 30 253 € | 57 600 € | 45 519 € |
| Non Current Liabilities | 15 751 € | 8 788 € | 0 € | - |
| Total Liabilities | 39 573 € | 39 041 € | - | - |
| Share Capital | - | - | - | - |
| Equity | 69 506 € | 83 125 € | 67 708 € | 67 160 € |
| Employees | 3 | 3 | 3 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 17 457.82 € | 17 470.06 € | 3 |
| 2023 Q4 | - | 18 079.68 € | 15 012.96 € | 3 |
| 2023 Q3 | - | 23 177.89 € | 19 801.37 € | 3 |
| 2023 Q2 | - | 17 788.3 € | 16 092.04 € | 3 |
| 2023 Q1 | - | 15 389.73 € | 15 452.71 € | 3 |
| 2022 Q4 | - | 15 229.2 € | 13 006.45 € | 3 |
| 2022 Q3 | - | 15 011.21 € | 14 938.72 € | 3 |
| 2022 Q2 | - | 18 127.84 € | 12 586.91 € | 3 |
| 2022 Q1 | - | 13 181.32 € | 12 690.52 € | 3 |
| 2021 Q4 | - | 16 516.1 € | 10 897.23 € | 3 |
| 2021 Q3 | - | 15 208.94 € | 12 184.58 € | 3 |
| 2021 Q2 | - | 10 169.41 € | 10 795.21 € | 3 |
| 2021 Q1 | - | 10 772.28 € | 11 447.01 € | 3 |
| 2020 Q4 | - | 8 954.43 € | 9 489.59 € | 3 |
| 2020 Q3 | - | 9 911.07 € | 10 516.61 € | 3 |
| 2020 Q2 | - | 8 557.78 € | 9 146.58 € | 3 |
| 2020 Q1 | - | 3 187.93 € | 3 341.12 € | 3 |
